Join to View Full Profile
1150 NW 14th StSte 410Miami, FL 33136
Phone+1 305-243-3100
Fax+1 305-243-8108
Dr. Granit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, EMG, Neurmuscular Disorders, 2012 - 2013- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 2012
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 2008 - 2009
Albert Einstein College of Medicine, Sue Golding GMS, Neuroscienece, 2004 - 2008
Istanbul University FomClass of 2003
Certifications & Licensure
FL State Medical License 2017 - 2027
NY State Medical License 2012 - 2019
American Board of Psychiatry and Neurology Neurology
American Board of Electrodiagnostic MedicineElectrodiagnostic Medicine
Clinical Trials
- BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial., Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-04-01 - Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.Robin C M Thomma, Susan K Halstead, Laura C de Koning, Evelin E J A Wiegers, Dawn S Gourlay
Brain. 2025-03-17 - 7 citationsPrognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis.Michael Benatar, Eric A Macklin, Andrea Malaspina, Mary-Louise Rogers, Eran Hornstein
Ebiomedicine. 2024-10-01
Press Mentions
Cartesian Therapeutics to Present Late-Breaking Data from Phase 1/2a Trial of RNA CAR T-cell Therapy in Patients with Generalized Myasthenia GravisMay 10th, 2022- ALS Center at University of Miami Receives State Funding for Patient CareSeptember 25th, 2020
Cartesian Initiates CAR-T Clinical Trial in Myasthenia GravisNovember 5th, 2019
Other Languages
- French, Turkish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
